Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 2 , Pages 110-116 , February 2010

Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: The DEMAND Study

  • M.C.E. Rossi

      Affiliations

    • Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Via Nazionale, 66030 S. Maria Imbaro, CH, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0872 570266; fax: +39 0872 570263.
    • ,
  • A. Nicolucci

      Affiliations

    • Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Via Nazionale, 66030 S. Maria Imbaro, CH, Italy
    • ,
  • F. Pellegrini

      Affiliations

    • Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Via Nazionale, 66030 S. Maria Imbaro, CH, Italy
    • ,
  • M. Comaschi

      Affiliations

    • Department of Internal Medicine, La Colletta Hospital, Genoa, Italy
    • ,
  • A. Ceriello

      Affiliations

    • Warwick Medical School, University of Warwick, Coventry, UK
    • ,
  • D. Cucinotta

      Affiliations

    • Department of Internal Medicine, Policlinico Universitario, Messina, Italy
    • ,
  • C. Giorda

      Affiliations

    • Metabolism and Diabetes Unit ASL TO5, Chieri (TO), Italy
    • ,
  • B. Pomili

      Affiliations

    • Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Via Nazionale, 66030 S. Maria Imbaro, CH, Italy
    • ,
  • U. Valentini

      Affiliations

    • Diabetologic Unit, Spedali Civili di Brescia, Brescia, Italy
    • ,
  • G. Vespasiani

      Affiliations

    • Diabetes and Metabolism Unit, Madonna del Soccorso Hospital, San Benedetto del Tronto, AP, Italy
    • ,
  • S. De Cosmo

      Affiliations

    • Unit of Endocrinology, Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG, Italy

Received 22 September 2008 ,Revised 4 February 2009 ,Accepted 27 February 2009.

References 

  1. Ritz E. Heart and kidney: fatal twins?. Am J Med. 2006;119(5 Suppl. 1):S31–S39
  2. Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG, et al. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome. Nutr Metab Cardiovasc Dis. 2008;18:31–38
  3. Bo S, Ciccone G, Gancia R, Rosato R, Grassi G, Merletti F, et al. Mortality within the first 10 years of the disease in type 2 diabetic patients. Nutr Metab Cardiovasc Dis. 2006;16:8–12
  4. Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, et al. Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. Nephrol Dial Transplant. 2008;23:1278–1284
  5. Franciosi M, Pellegrini F, Sacco M, De Berardis G, Rossi MC, Strippoli GF, et al. IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group. Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study. Clin J Am Soc Nephrol. 2007;2:984–991
  6. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens. 2003;16:952–958
  7. Chandie Shaw PK, Berger SP, Mallat M, Frölich M, Dekker FW, Rabelink TJ. Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian subjects. Diabetes Care. 2007;30:1840–1844
  8. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21–28
  9. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RRUKPDS. Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes. 2006;55:1832–1839
  10. Cignarelli M, Lamacchia O. Obesity and kidney disease. Nutr Metab Cardiovasc Dis. 2007;17:757–762
  11. Bello AK, de Zeeuw D, El Nahas M, Brantsma AH, Bakker SJ, de Jong PE, et al. Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant. 2007;22:1619–1627
  12. de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol. 2007;18:235–243
  13. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 1996;97:2601–2610
  14. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-κB. Nat Med. 2005;11:183–190
  15. Yudkin JS. Inflammation, obesity, and the metabolic syndrome. Horm Metab Res. 2007;39:707–709
  16. World Health Organization . Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Geneva: World Health Organization; 1999;
  17. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421–426
  18. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med. 2003;139:901–906
  19. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112:969–975
  20. Ruggenenti P, Remuzzi G. Time to abandon microalbuminuria?. Kidney Int. 2006;70:1214–1222
  21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470
  22. Morales E, Valero MA, Leon M, Hernandez E, Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis. 2003;41:319–327
  23. Solerte SB, Fioravanti M, Schifino N, Ferrari E. Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy. Int J Obes. 1989;13:203–211
  24. Serra A, Granada ML, Romero R, Bayés B, Cantón A, Bonet J, et al. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr. 2006;25:400–408
  25. Tong PC, Lee ZS, Sea MM, Chow CC, Ko GT, Chan WB, et al. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes. Arch Intern Med. 2002;162:2428–2435
  26. Gansevoort RT, Verhave JC, Hillege HL, Burgerhof JG, Bakker SJ, de Zeeuw D, et al. for the PREVEND Study Group. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int. 2005;94(Suppl):S28–S35
  27. Strippoli GF, Craig M, Deeks JJ, Schena FP, Craig JC. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ. 2004;329:828–838

PII: S0939-4753(09)00045-3

doi: 10.1016/j.numecd.2009.02.013

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 2 , Pages 110-116 , February 2010

Article Tools

* Image Usage & Resolution